top of page

Prestigious funding secured for improving cancer immunotherapy through blood tests

Updated: Feb 2, 2022

12/01/22 - Edith Cowan University research into a blood test to better treat melanoma and lung cancer has won a highly sought after international grant.

Associate Professor Elin Gray, from the ECU Centre for Precision Health, will lead the study, funded by Thermo Fisher Scientific for $200,000 over the next six months.

Immunotherapy is a type of cancer treatment that helps your immune system fight cancer.

But the treatment does not work in all patients and can lead to severe side effects. Features of the patient’s immune system and tumour could provide clues of in which patients the therapy would work.

“These are two malignancies where immunotherapy is making the biggest impact and we hope this study will support the integration of our studies in cancer genetics and immunogenetics for the development of test that can better guide treatment decisions.”

Article taken from ECU Newsroom. Read the full article Here



bottom of page